Since IL-17 not only mediates the synthesis of ICAM-1 and diverse cytokines (IL-6 and TNF-α, etc), but also accelerates collagen degradation via diminishing collagen and proteo glycan synthesis while enhancing bone erosion, its inhibition was believed to be an effective way to ameliorate RA. Here, ICAM1 is linked to rheumatoid arthritis.